Perceptive Advisors LLC Immatics N.V. Call Options Transaction History
Perceptive Advisors LLC
- $2.39 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.5MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$81.3 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$50.6 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$47.6 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$40.3 Million0.39% of portfolio
-
Vestal Point Capital, LP New York, NY7.19MShares$39.8 Million2.32% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $422M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...